Chronic Pelvic Pain Syndrome & Prostatitis: Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 166: | Line 166: | ||
=== Management === | === Management === | ||
==== | ==== <span style="color:#ff0000">Acute prostatitis</span> ==== | ||
* '''<span style="color:#ff0000">1<sup>st</sup> Line: Trimethoprim/Sulfamethoxazole or Fluoroquinolone[https://www.auanet.org/meetings-and-education/for-medical-students/medical-students-curriculum/adult-uti §]''' | * '''<span style="color:#ff0000">1<sup>st</sup> Line: Trimethoprim/Sulfamethoxazole or Fluoroquinolone[https://www.auanet.org/meetings-and-education/for-medical-students/medical-students-curriculum/adult-uti §]''' | ||
* '''<span style="color:#ff0000">2<sup>nd</sup> Line: 2<sup>nd</sup> generation cephalosporin''' | * '''<span style="color:#ff0000">2<sup>nd</sup> Line: 2<sup>nd</sup> generation cephalosporin''' | ||
| Line 175: | Line 175: | ||
* '''<span style="color:#ff0000">In patients with acute prostatitis with ESBL or suspected ESBL organisms (usually associated with transrectal prostate biopsies), treatment with a carbapenem (ertapenem, imipenem, or meropenem),</span>''' amikacin, or colistin '''for at least 10 to 14 days is recommended''' | * '''<span style="color:#ff0000">In patients with acute prostatitis with ESBL or suspected ESBL organisms (usually associated with transrectal prostate biopsies), treatment with a carbapenem (ertapenem, imipenem, or meropenem),</span>''' amikacin, or colistin '''for at least 10 to 14 days is recommended''' | ||
==== | ==== <span style="color:#ff0000">Chronic Pelvic Pain Syndrome (CPPS)</span> ==== | ||
* Medical therapies that have been properly evaluated in RCTs in CPPS: antibiotics, α-adrenergic blockers, anti-inflammatory agents, hormonal therapies, phytotherapies, and pregabalin | * Medical therapies that have been properly evaluated in RCTs in CPPS: antibiotics, α-adrenergic blockers, anti-inflammatory agents, hormonal therapies, phytotherapies, and pregabalin | ||
* Minimally invasive therapies that have been properly evaluated in RCTs in CPPS: extracorporeal shockwave therapy (ESWT), transurethral microwave therapy (TUMT), and neuromodulation (electrostimulation, botulinum toxin). | * Minimally invasive therapies that have been properly evaluated in RCTs in CPPS: extracorporeal shockwave therapy (ESWT), transurethral microwave therapy (TUMT), and neuromodulation (electrostimulation, botulinum toxin). | ||